- Home
- BMR vs ONCY Comparison
BMR vs ONCY Comparison
Compare BMR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- ONCY
- Stock Information
- Founded
- BMR 2009
- ONCY 1998
- Country
- BMR Israel
- ONCY Canada
- Employees
- BMR N/A
- ONCY N/A
- Industry
- BMR Computer Software: Prepackaged Software
- ONCY Pharmaceuticals and Biotechnology
- Sector
- BMR Technology
- ONCY Health Care
- Exchange
- BMR Nasdaq
- ONCY Nasdaq
- Market Cap
- BMR 59.3M
- ONCY 56.2M
- IPO Year
- BMR 2023
- ONCY 1999
- Fundamental
- Price
- BMR $2.90
- ONCY $0.73
- Analyst Decision
- BMR
- ONCY Strong Buy
- Analyst Count
- BMR 0
- ONCY 2
- Target Price
- BMR N/A
- ONCY $4.00
- AVG Volume (30 Days)
- BMR 225.7K
- ONCY 564.7K
- Earning Date
- BMR 03-26-2025
- ONCY 03-06-2025
- Dividend Yield
- BMR N/A
- ONCY N/A
- EPS Growth
- BMR N/A
- ONCY N/A
- EPS
- BMR N/A
- ONCY N/A
- Revenue
- BMR $2,955,000.00
- ONCY N/A
- Revenue This Year
- BMR $21.52
- ONCY N/A
- Revenue Next Year
- BMR N/A
- ONCY N/A
- P/E Ratio
- BMR N/A
- ONCY N/A
- Revenue Growth
- BMR 2.25
- ONCY N/A
- 52 Week Low
- BMR $2.40
- ONCY $0.67
- 52 Week High
- BMR $10.25
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- BMR 34.17
- ONCY 40.10
- Support Level
- BMR $3.17
- ONCY $0.71
- Resistance Level
- BMR $3.65
- ONCY $0.79
- Average True Range (ATR)
- BMR 0.23
- ONCY 0.04
- MACD
- BMR -0.06
- ONCY 0.00
- Stochastic Oscillator
- BMR 6.74
- ONCY 32.71
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.